The finding of ZNF224 as one of the factors enhancing NF-kB signaling may contribute to clarify the molecular mechanisms of NF-kB deregulation in CLL and to develop new strategies for targeting this pathway. The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.